Your browser doesn't support javascript.
loading
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer.
Ferrari, Silvia Martina; Elia, Giusy; Ragusa, Francesca; Paparo, Sabrina Rosaria; Mazzi, Valeria; Miccoli, Mario; Galdiero, Maria Rosaria; Varricchi, Gilda; Foddis, Rudy; Guglielmi, Giovanni; Spinelli, Claudio; La Motta, Concettina; Benvenga, Salvatore; Antonelli, Alessandro; Fallahi, Poupak.
Affiliation
  • Ferrari SM; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Elia G; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Ragusa F; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Paparo SR; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Mazzi V; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Miccoli M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Galdiero MR; Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy; WAO Center of Excellence, Naples, Italy; Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (
  • Varricchi G; Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy; WAO Center of Excellence, Naples, Italy; Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (
  • Foddis R; Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Guglielmi G; U.O. Medicina Preventiva Del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Spinelli C; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • La Motta C; Department of Pharmacy, University of Pisa, Pisa, Italy.
  • Benvenga S; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Antonelli A; Master Program on Childhood, Adolescent and Women's Endocrine Health, University of Messina, Messina, Italy.
  • Fallahi P; Interdepartmental Program of Molecular and Clinical Endocrinology and Women's Endocrine Health, Azienda Ospedaliera Universitaria Policlinico 'G. Martino', Messina, Italy.
Expert Opin Investig Drugs ; 30(9): 913-921, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34428101
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication: